Affiliation of authors: Laboratory of Molecular Microbiology,National Institute of Allergy and Infectious Diseases, Bethesda, MD.
Correspondence to: Kuan-Teh Jeang, M.D., PhD., National Institutes of Health, Bldg. 4, Rm. 306, Bethesda, MD 20892 (e-mail: kj7e{at}nih.gov).
Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent for adult T-cell leukemia (ATL). In vivo, nuclei of ATL cells are morphologically altered [reviewed in (1)] and karyotypically abnormal [reviewed in (2)] with frequent trisomies (e.g., chromosomes 3 and 7). Lymphocytes infected ex vivo with HTLV-1 also show chromosomal changes (3). Collectively, these findings suggest that a loss in the ability of the host cell to maintain genome integrity occurs as a consequence of infection by HTLV-1. It is reasonable that an ultimate sequela of loss of DNA integrity is cellular transformation.
Among the HTLV-1-encoded open-reading frames, the 40-kd nuclear phosphoprotein Tax has been significantly implicated in transformation. Tax is a well-characterized, potent transcriptional activator of HTLV-1 LTR-directed transcription (4,5). It is interesting that singular overexpression of the Tax protein has been found to sufficiently immortalize T lymphocytes (6) and to transform rat fibroblasts (7). Several years ago, it was observed that cells that overexpress only the Tax protein showed clastogenic and aneuploidogenic DNA changes similar to those found in ATL cells (8). Mechanistically, how a transcriptional activator protein engenders cellular DNA damage has long been a perplexing issue for HTLV-1 researchers.
Several recent studies have now contributed two perspectives on how Tax might influence the cellular capacity to correct damaged DNA. In one view, cells, in recognizing ambiently damaged DNA, arrest in certain phases of the cell cycle, permitting time for repair. Tax, through interactions with inhibitors of cyclin-dependent kinases (9,10) and G1 cyclins (11), dysregulates this cell cycle control and removes these corrective pauses. Indirectly then, in accelerating uncontrolled cell cycle progression, Tax allows the replication of DNA lesions and their propagation into progeny cellular genomes. In a second view, Tax is considered to directly affect the machinery for DNA repair. Thus, Tax has been shown to repress the expression of DNA polymerase-ß (12), an enzyme important for base-excision repair, and the MAD1 protein, a factor likely critical for surveillance against aneuploidies (13).
In this issue of the Journal, Philpott and Buehring (14) provide further evidence that the Tax proteins from HTLV-1, HTLV-2, and the related bovine leukemia virus (BLV) specifically affect base-excision repair. Using virus-transformed cell lines and transient DNA-transfection assays, the authors showed that all three Tax proteins markedly decreased the ability of base-excision-dependent repair of oxidative DNA damage in cells. This observation is important and is consistent with the natural history of HTLV-1 and BLV in cellular transformation. However, it is somewhat puzzling that the authors demonstrated a similar repair-suppressive activity for the HTLV-2 Tax protein. Other investigators (15) found that HTLV-2 Tax was poorly efficient in inducing a damaged DNA cellular phenotype; others (16) predicted that Tax 2 was not able to bind to a tumor suppressor in the manner that has been shown for Tax 1. Indeed, it currently remains unresolved whether HTLV-2 is linked to a malignant disease.
It should be noted that, simultaneous with the article by Philpott and Buehring (14) on base-excision repair, Kao and Marriott (17) have presented evidence elsewhere that is consistent with a profound effect of Tax 1 on nucleotide excision repair. At the same time, Yoshida and colleagues (18) have directly observed an increased frequency of point mutations in the cellular genomes of Tax 1-expressing cells. The latter finding is consistent with a general reduction in fidelity of DNA synthesis in cells that synthesize the HTLV-1 oncoprotein. Together, these three studies converge to address the long-standing observation of substantial aneuploidogenic and clastogenic DNA damage in ATL cells. Rather than agreeing on a single process, these studies emphasize the multiple mechanisms through which HTLV-1 Tax affects overlapping and sometimes redundant cellular checks on genome homeostasis. Indeed, the need for the virus to defeat several corrective safeguards in the cell possibly explains the long latency (approximately 20 years) between time of infection by HTLV-1 and clinical manifestation of ATL. The recent studies have, indeed, added much to our understanding of the cytogenetic alterations in ATL. Whether these proposed mechanisms fully explain the subversion of cell-corrective processes by HTLV-1 awaits further investigation.
REFERENCES
1 Uchiyama T. ATL and HTLV-I: in vivo cell growth of ATL cells. J Clin Immunol 1996;16:305-14.[Medline]
2 Yoshida M, Seiki M. Recent advances in the molecular biology of HTLV-1: trans-activation of viral and cellular genes. Annu Rev Immunol 1987;5:541-59.[Medline]
3 Arima N, Daitoku Y, Ohgaki S, Fukumori J, Tanaka H, Yamamoto Y, et al. Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T cell leukemia. Blood 1986;68:779-82.[Abstract]
4 Seiki M, Inoue J, Takeda T, Yoshida M. Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J 1986;5:561-5.[Abstract]
5 Jeang KT, Boros I, Brady J, Radonovich M, Khoury G. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence. J Virol 1988;62:4499-509.[Medline]
6 Grassmann R, Dengler C, Muller-Fleckenstein I, Fleckenstein B, McGuire K, Dokhelar MC, et al. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci U S A 1989;86:3351-5.[Abstract]
7 Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci U S A 1990;87:1071-5.[Abstract]
8 Majone F, Semmes OJ, Jeang KT. Induction of micronuclei by HTLV-I Tax: a cellular assay for function. Virology 1993;193:456-9.[Medline]
9 Suzuki T, Kitao S, Matsushime H, Yoshida M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J 1996;15:1607-14.[Abstract]
10 Low KG, Dorner LF, Fernando DB, Grossman J, Jeang KT, Comb MJ. Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a. J Virol 1997;71:1956-62.[Abstract]
11
Neuveut C, Low KG, Maldarelli F, Schmitt I, Majone F,
Grassmann R, et al. Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of
cyclin D-cdk and p110Rb. Mol Cell Biol 1998;18:3620-32.
12 Jeang KT, Widen SG, Semmes OJ 4th, Wilson SH. HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science 1990;247:1082-4.[Medline]
13 Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 1998;93:81-91.[Medline]
14
Philpott SM, Buehring GC. Defective DNA repair in cells with
human T-cell leukemia/bovine leukemia viruses: role of tax gene. J Natl Cancer Inst 1999;91:933-42.
15 Semmes OJ, Majone F, Cantemir C, Turchetto L, Hjelle B, Jeang KT. HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs. Virology 1996;217:373-9.[Medline]
16
Lee SS, Weiss RS, Javier RT. Binding of human virus
oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large
tumor suppressor protein. Proc Natl Acad Sci U S A 1997;94:6670-5.
17
Kao SY, Marriott SJ. Disruption of nucleotide excision repair
by the human T-cell leukemia virus type 1 tax protein. J Virol 1999;73:4299-304.
18 Miyake H, Suzuki T, Hirai H, Yoshida M. Trans-activator Tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome. Virology 1999;253:155-61.[Medline]
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
||||
|
Oxford University Press Privacy Policy and Legal Statement |